Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
1
Trials led
0
Active
0
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Early Phase 1
1
Trials by status
Withdrawn
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study—Early Ph 1Withdrawnnot disclosed